Literature DB >> 20127350

Neurological manifestations of Behçet's disease in Japan: a study of 54 patients.

Haruko Ideguchi1, Akiko Suda, Mitsuhiro Takeno, Yohei Kirino, Atsushi Ihata, Atsuhisa Ueda, Shigeru Ohno, Yasuhisa Baba, Yoshiyuki Kuroiwa, Yoshiaki Ishigatsubo.   

Abstract

The type and frequency of neurological manifestations of Behçet's disease (BD) vary with ethnicity. We analyzed the neurological manifestations of BD in Japanese patients. All patients undergoing treatment at one of the two Yokohama City University hospitals from July 1991 to December 2007 and who fulfilled the Japanese criteria for BD revised in 1987 were studied retrospectively by chart review. Patients had been neurologically assessed by neurologists. We recorded neurological signs and symptoms, magnetic resonance imaging or computed tomography findings, and results of cerebrospinal fluid examinations from the records of each patient. We studied 412 patients with BD, of whom 54 (13%) had neurological involvement (neuro-Behçet's disease: NB). NB patients included a significantly higher proportion of males (61%) than non-NB patients (42%, P = 0.009). The majority of patients (n = 38, 70%) had acute parenchymal NB, 15 (28%) had chronic progressive parenchymal NB, and 1 (2%) had the non-parenchymal type. Headache and fever were more frequently reported by patients with acute parenchymal NB. Personality changes, sphincter disturbances, involuntary movements, and ataxia occurred predominantly in patients with chronic progressive parenchymal NB. Lesions were distributed throughout the CNS, but mainly in the brainstem, white matter, and basal ganglia. Analysis of end-point clinical outcomes revealed a poor prognosis for patients with chronic progressive NB. In Japan, most NB patients have the parenchymal type, and male gender is a predisposing factor. Because of the unfavorable prognosis associated with chronic progressive NB, development of effective therapies are urgently needed.

Entities:  

Mesh:

Year:  2010        PMID: 20127350     DOI: 10.1007/s00415-010-5454-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  48 in total

1.  The factor V Leiden mutation and the prothrombin G20210A mutation was not found in Japanese patients with pulmonary thromboembolism.

Authors:  A Ro; M Hara; A Takada
Journal:  Thromb Haemost       Date:  1999-12       Impact factor: 5.249

2.  Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq.

Authors:  A Al-Araji; K Sharquie; Z Al-Rawi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

3.  Neuro-Behçet's disease (isolated cerebral thrombophlebitis excluded). Clinical pattern, prognostic factors, treatment and long term follow-up.

Authors:  A Sbaï; B Wechsler; P Duhaut; L T H Du-Boutin; Z Amoura; P Cacoub; P Godeau; J C Piette
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

4.  EULAR recommendations for the management of Behçet disease.

Authors:  G Hatemi; A Silman; D Bang; B Bodaghi; A M Chamberlain; A Gul; M H Houman; I Kötter; I Olivieri; C Salvarani; P P Sfikakis; A Siva; M R Stanford; N Stübiger; S Yurdakul; H Yazici
Journal:  Ann Rheum Dis       Date:  2008-01-31       Impact factor: 19.103

Review 5.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

6.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

Authors:  G Akman-Demir; P Serdaroglu; B Tasçi
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

7.  Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.

Authors:  José Ma Ricart; Amparo Vayá; José Todolí; Javier Calvo; Piedad Villa; Amparo Estellés; Francisco España; Marisa Santaolaria; Dolores Corella; Justo Aznar
Journal:  Thromb Haemost       Date:  2006-04       Impact factor: 5.249

8.  Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.

Authors:  S Hirohata; K Isshi; H Oguchi; T Ohse; H Haraoka; A Takeuchi; T Hashimoto
Journal:  Clin Immunol Immunopathol       Date:  1997-01

9.  Validation of the classification criteria commonly used in Korea and a modified set of preliminary criteria for Behçet's disease: a multi-center study.

Authors:  H K Chang; S S Lee; H J Bai; Y W Lee; B Y Yoon; C H Lee; Y H Lee; G G Song; W T Chung; S W Lee; J Y Choe; C G Kim; D K Chang
Journal:  Clin Exp Rheumatol       Date:  2004 Jul-Aug       Impact factor: 4.473

10.  Association of HLA-B51 and lack of association of class II alleles with Behçet's disease.

Authors:  N Mizuki; S Ohno; H Tanaka; K Sugimura; T Seki; N Mizuki; J Kera; G Inaba; K Tsuji; H Inoko
Journal:  Tissue Antigens       Date:  1992-07
View more
  19 in total

1.  Atypical manifestations in Brazilian patients with neuro-Behçet's disease.

Authors:  Lívia Almeida Dutra; Célio Roberto Gonçalves; Pedro Braga-Neto; José Luiz Pedroso; Alberto Alain Gabbai; Orlando Graziani Povoas Barsottini; Alexandre Wagner Silva de Souza
Journal:  J Neurol       Date:  2011-12-15       Impact factor: 4.849

Review 2.  Neurological complications of Behçet's syndrome.

Authors:  Desmond Kidd
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

Review 3.  Parenchymal neuro-Behçet disease with erectile dysfunction and micturition disturbances: case report and literature review.

Authors:  Ali Taylan; Merih Birlik
Journal:  Rheumatol Int       Date:  2017-11-07       Impact factor: 2.631

Review 4.  Infliximab for patients with neuro-Behcet's disease: case series and literature review.

Authors:  Afshin Borhani Haghighi; Anahid Safari; Mohammad Ali Nazarinia; Zahra Habibagahi; Saeedeh Shenavandeh
Journal:  Clin Rheumatol       Date:  2011-03-24       Impact factor: 2.980

5.  [Epidemiology and clinical aspects of Adamantiades-Behçet disease in Gemany. Current data].

Authors:  A Altenburg; A Mahr; C Maldini; C E Kneifel; L Krause; I Kötter; T Stache; N G Bonitsis; C C Zouboulis
Journal:  Ophthalmologe       Date:  2012-06       Impact factor: 1.059

Review 6.  Neurological complications of Behçet's syndrome.

Authors:  D P Kidd
Journal:  J Neurol       Date:  2017-03-10       Impact factor: 4.849

7.  Simultaneous involvement of nervous and gastrointestinal systems in Behçet's disease.

Authors:  Jae Yeol Lee; Ji-Youn Park; En Hyung Kim; Mi Jin Hee Tak; Eun-So Lee
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

8.  Nummular headache and pituitary lesion: A case report and literature review.

Authors:  Chi Chui; Wei Hsi Chen; Hsin Ling Yin
Journal:  Ann Indian Acad Neurol       Date:  2013-04       Impact factor: 1.383

9.  Cognitive Functioning and Silent Neurological Manifestations in Behçet's Disease with Ocular Involvement.

Authors:  Yavuz Altunkaynak; Şebnem Usta; Devrimsel Harika Ertem; Ayhan Köksal; Ayten Ceyhan Dırıcan; Sevim Baybaş
Journal:  Noro Psikiyatr Ars       Date:  2018-07-09       Impact factor: 1.339

Review 10.  Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features.

Authors:  Paolo Mora; Chiara Menozzi; Jelka G Orsoni; Pierangela Rubino; Livia Ruffini; Arturo Carta
Journal:  Orphanet J Rare Dis       Date:  2013-01-29       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.